Related Experiment Videos
"Good risk" non-Hodgkin lymphomas: approaches to management
Seminars in Hematology
|January 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Germline predisposition in myeloproliferative neoplasms.
Seminars in hematology·2026
Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.
Seminars in hematology·2026
Pain in SCD-Many mechanisms and mysteries.
Seminars in hematology·2026
The many facets of cardiopulmonary complications in sickle cell disease.
Seminars in hematology·2026
Global research landscape of vascular access device-related complications in oncology: A bibliometric analysis.
The journal of vascular access·2026
Surgical Outcomes and Histopathological Risk Factors in Periocular Basal Cell Carcinoma: A Single-Centre Study of 100 Patients.
Turkish journal of ophthalmology·2026
Nationwide Survey of Association Between Fever and Epileptic Seizure in CDKL5 Deficiency Disorder Revealed Therapeutic Implications.
Annals of clinical and translational neurology·2026
Deep Generative Model of Macrophage Immune Response for Hepato-intestinal Tumor Therapy Optimization.
Cyborg and bionic systems (Washington, D.C.)·2026